Mather Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Mather Group's GILD Position: Q3 2026 in Review
Mather Group increased its Gilead Sciences (GILD) stake by 5% in Q3 2026, buying an estimated $232K and bringing the position to 35,004 shares worth $5.22M. The position accounts for 0.04% of the portfolio, ranked #166.
Mather Group first reported a position in GILD in Q3 2022 and has held it in 17 quarters since. 1,582 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Mather Group held 35,004 shares of Gilead Sciences worth $5.22M as of Q3 2026.
- Mather Group bought 1,657 Gilead Sciences shares in Q3 2026, an estimated $232K.
- Gilead Sciences made up 0.04% of Mather Group's portfolio in Q3 2026, its #166 holding.
- Mather Group first reported a position in Gilead Sciences in Q3 2022 and has held it in 17 quarters since.
- 1,582 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.